2025 · AI Revolution in Vision Care

Multimodal AI Vision Robot

Smart vision care within everyone's reach

The world's first vision robot system covering Screening → Diagnosis → Treatment.
Professional screening in 3 minutes, even in remote areas.

Scroll down
01

Project Summary

Built on years of research and clinical experience in ophthalmology and AI.

♾

World First

VisionDiagnose: 10+ proprietary AI models for natural language intake + medical image analysis + eye-tracking fusion diagnosis.

⏱

Proven Deployment

VisionScan is already deployed in Zhejiang, Sichuan, Xinjiang (China) and Ethiopia.

🎯

Precision

0.01∆ strabismus measurement; industry-leading heterophoria accuracy.

🔄

Full Loop

Hospital–community–optical store coverage: VisionScan → VisionDiagnose → VisionTreat in one flow.

0 B Global ophthalmic market 2030
0 B China ophthalmic market 2025
0 % Refractive error coverage
0 K People per doctor gap globally
02

Pain Points

WHO: Untreated refractive error causes 111M vision impairment globally.

Care

Staff & skill gap

  • Shortage of optometrists, variable quality
  • Short visits, high misdiagnosis
  • Diagnosis relies on subjective experience
Tools

Lack of smart devices

  • Manual, experience-dependent exams
  • Subjective results
  • Few quantified vision analysis tools
Service

Limited coverage

  • Rural areas lack professional care
  • Asia: 50,000+ people per doctor
  • Africa: 1 optometrist per 400,000
03

Products & Solutions

Three products for a full AI vision-care loop.

Screening

VisionScan

Mobile vision screening

Remote screening: myopia, strabismus, PD, dark adaptation; refraction, phoria, AC/A, NPC, acuity, contrast sensitivity.

Mobile app AMD/diabetic retinopathy screening Any setting
Diagnosis

VisionDiagnose

AI diagnosis engine

Natural language + image analysis; auto output of refraction, strabismus. 0.01∆ phoria, Kappa in seconds.

Multimodal model 10+ dedicated AI models Expert-level
Treatment

VisionTreat

Vision treatment robot

Amblyopia, convergence, strabismus intervention. First full Screening–Diagnosis–Treatment AI vision robot.

Hardware robot Precise intervention Full loop

Key advantages

✓ High AI precision: phoria to 0.01∆
✓ All settings: hospital, community, rural, overseas
✓ Full care loop: screening to intervention in one place
04

Technology & Research

Leading mobile ophthalmology research · Strong real-world deployment and iteration.

Multimodal fusion

Deep fusion of images and eye-tracking; high complexity; models improve with real-world use.

Smart detection

Medical image understanding, smart subjective assessment, eye-movement big data; micropixel-level capture.

Patient-facing LLM

Natural language, context-aware; adapts exam path to patient feedback; slow-thinking reasoning for accuracy.

Patents & papers

4 international patents · 15 SCI papers · AOA W.Feinbloom & G.Fry awards · $12.83M NIH funding.

Global deployment

Xinjiang Hetian Sichuan Liangshan Sichuan Kangding Jiaxing · Shanghai · Chengdu Ethiopia
05

Core Team

Tsinghua + top industry backgrounds.

陈建文 陈建文

陈建文 Jianwen Chen

Co-founder · PhD

Tsinghua EE · 20+ years video analysis & AI

Matteo Tomasi Tomasi

Matteo Tomasi

Co-founder · PhD, MSc, Eng

NIH SBIR PI · Commercialized NIH products

徐枫 徐枫

徐枫

Chief AI Scientist · PhD

UPenn postdoc · Samsung Research · Bingo Tech

06

Business Model

Diversified revenue · Targeting billion-dollar leadership.

AI vision robot sales

Hardware to hospitals, optical chains, vision centers; $14K–$2.1M per unit; B2B2C.

Agent subscription

Per terminal/outlet annual or monthly; per-test pricing.

Data monetization

Anonymous insights; research services for government, pharma, institutions.

Tech licensing

Core AI to medical groups and OEMs; custom model development.

07

Contact

Bridging vision care with AI — professional eye health within reach.

Company VisionX Robotics Inc.
Address 1209 North Orange Street, Wilmington, DE, United States @Delaware
Team size 30

Smart vision care within everyone's reach

Largest vision-care AI platform in China

Reshaping the $230B global ophthalmic market with AI